Valye reports for unlimited access

MGP Ingredients Inc is a publicly traded company listed on NASDAQ under the ticker MGPI. The company provides financial disclosures through SEC filings including annual 10-K and quarterly 10-Q reports. As of the first quarter ending March 31, 2026, the company reported a significant net loss and negative earnings per share. Liquidity metrics indicate a current ratio of 2.74, suggesting the company has more than twice the current assets relative to current liabilities. The company has recently reported fourth-quarter and full-year 2025 financial results, with earnings and revenues surpassing estimates. Leadership changes occurred in early 2026 involving key executive departures. Recent news also highlights increased implied volatility in the company's stock options.

EMCOR Group, Inc. operates primarily in the United States as a specialty contractor offering electrical and mechanical construction and facilities services, building services, and industrial services. The company serves a diverse customer base across commercial, technology, manufacturing, industrial, healthcare, utility, and institutional sectors through approximately 100 operating subsidiaries. Its business is organized into four main reportable segments: United States electrical construction and facilities services, United States mechanical construction and facilities services, United States building services, and United States industrial services. In December 2025, EMCOR sold its United Kingdom operations. The company recognizes revenue upon transfer of promised goods or services to customers. In 2025, EMCOR completed several acquisitions, including Miller Electric, contributing significantly to revenue growth. The company maintains a revolving credit facility to support liquidity and capital needs.

Lakeland Financial Corp operates as a financial services company primarily engaged in commercial and consumer lending. The company’s loan portfolio is segmented into various categories including commercial and industrial loans, commercial real estate loans, and consumer 1-4 family mortgage loans, as detailed in its annual 10-K filing. The company maintains liquidity with significant cash and cash equivalents and reports quarterly financial results including net income and earnings per share. It also has a dividend policy and experiences insider share transactions. The company’s financial performance and business developments are regularly reported in financial news outlets.

Regeneron Pharmaceuticals Inc operates as a fully integrated biotechnology company engaged in the invention, development, manufacturing, and commercialization of medicines targeting serious diseases. The company has a broad clinical pipeline with approximately 45 product candidates and several marketed products, including EYLEA, EYLEA HD, Dupixent, Libtayo, Praluent, Evkeeza, and Inmazeb. Regeneron shares profits and collaborates with partners such as Sanofi and Bayer for commercialization outside the United States. The company maintains substantial liquidity and invests in expanding its research and manufacturing capabilities. Its business model depends significantly on the commercial success of its key products and the ability to advance its clinical pipeline.

Blackstone Mortgage Trust, Inc. operates as a real estate finance company and REIT that originates, acquires, and manages senior loans and other debt or credit-oriented investments collateralized by commercial real estate in major global markets including North America, Europe, and Australia. The company’s portfolio primarily consists of senior, floating rate mortgage loans secured by high-quality institutional assets. BXMT is externally managed by BXMT Advisors L.L.C., a subsidiary of Blackstone Inc., leveraging Blackstone’s global real estate platform, investment expertise, and extensive market data. The company finances its investments through a variety of secured credit facilities, CLOs, securitizations, and other asset-level financing structures. BXMT also holds owned real estate assets and participates in joint ventures focused on bank loan portfolios and net lease properties. The company operates under investment guidelines designed to limit concentration risk and maintain REIT and regulatory compliance. BXMT is listed on the NYSE under the ticker BXMT.

KT CORP operates as a major telecommunications provider in South Korea, offering a broad range of services including mobile telephony, fixed-line and VoIP telephone services, broadband internet access, data communication, media and content services such as IPTV and digital media, financial services through its subsidiary BC Card, and real estate development via KT Estate. The company generates revenue from monthly fees, usage charges, interconnection fees, content services, credit card fees, and sales of goods including handsets and real estate units. KT pursues growth through acquisitions, joint ventures, and portfolio optimization. In 2025, KT expanded its mobile subscriber base to 29.0 million, including growth in IoT and MVNO subscribers, and increased average revenue per user driven by 5G and roaming services. Fixed-line services showed mixed trends with broadband and data communication growing, while traditional telephone services declined. Media and content revenues declined slightly due to divestitures but IPTV subscriber numbers increased. Financial services revenue decreased due to lower credit card transaction volumes. Operating expenses were managed with reductions in employee costs and impairment losses, despite increases in sales commissions and service costs related to cloud operations and cybersecurity incident responses. The company maintains a liquidity position with a current ratio near 1.0 and a cash ratio of 0.26 as of end 2024. KT holds treasury shares and manages capital structure with a gearing ratio of 27%.

Park Ha Biological Technology Co., Ltd. is a China-based company engaged in the development, manufacturing, and sale of skincare products and operation of franchise stores. The company’s product portfolio includes functional skincare products developed through collaborations with biological laboratories and supply chain partners. It operates both directly owned and franchised stores primarily in major and mid-tier Chinese cities. The company targets primarily young adult and middle-aged women in urban business districts, with plans to expand product offerings to male customers. The business model combines product sales, franchise fees, and training services. Park Ha emphasizes quality control through supplier audits and factory inspections and maintains a diversified management team with extensive industry experience. The company has recently completed public offerings to raise capital for expansion and R&D investments.

Aura Minerals Inc. is a gold and copper mining company with operations across the Americas, including six wholly-owned mines in Honduras, Brazil, and Mexico. The company pursues growth through strategic acquisitions, mine expansions, and efficiency improvements, emphasizing operational sustainability and disciplined capital management. Key development projects include the Matupá Gold Project in Brazil, which features a processing plant with a capacity of 1.3 million tonnes per annum and mineral resources and reserves classified under S-K 1300 standards. Aura Minerals reported consolidated revenue of US$921.7 million and adjusted EBITDA of US$547.8 million for 2025, with capital expenditures primarily directed toward mine construction and expansion. The company maintains significant exploration potential with over 551,000 hectares of mineral rights and continues to advance multiple near-mine and regional targets. Its financial position includes loans and debentures totaling approximately US$411 million as of year-end 2025, with compliance to financial covenants and collateral arrangements. The company’s revenue is concentrated among a few key customers and is sensitive to fluctuations in metal prices and foreign exchange rates.

Applied Industrial Technologies Inc operates as a distributor of industrial products and services. The company manages inventory using LIFO for U.S. inventories and average cost for foreign inventories, monitoring inventory turnover ratios. It maintains a focus on receivables management, with days sales outstanding around 57 days and low provisions for uncollected accounts. The company has a strong liquidity profile with current assets significantly exceeding current liabilities. It has access to a $900 million revolving credit facility to support working capital and corporate purposes. Recent corporate governance actions include dividend declarations and share repurchase authorizations.

Axogen, Inc. focuses on developing and commercializing technologies for peripheral nerve repair and regeneration. The company’s product portfolio includes the Avance nerve allograft, which is FDA-approved for sensory, mixed, and motor nerve discontinuities, and a range of Axoguard products made from porcine extracellular matrix for nerve protection and repair. The products address nerve injuries caused by trauma or surgery across multiple clinical areas including extremities, oral maxillofacial and head and neck, breast reconstruction, and urology. Axogen estimates the U.S. total addressable market for its current portfolio at least $5.6 billion. The company sells primarily in the U.S. and select international markets and supports its products with extensive clinical data and surgeon education programs. Recent FDA approval of Avance as a biologic product marks a regulatory milestone, with commercial availability anticipated in early Q2 2026. The company has experienced net losses historically but maintains substantial liquidity as of Q1 2026.

Expand Energy Corp, headquartered in the U.S., is the largest independent natural gas producer in the country by net daily production. The company’s operations span major shale plays including the Haynesville and Bossier Shales in Louisiana and Texas, the Marcellus Shale in Pennsylvania, and the Marcellus and Utica Shales in West Virginia and Ohio. Formed through the Southwestern Merger in October 2024, Expand Energy combines a leading natural gas portfolio with a resilient financial foundation and investment grade credit ratings. The company’s strategy centers on responsible development of natural gas, oil, and natural gas liquids (NGL), focusing on operational efficiencies, marketing, financial discipline, and sustainability initiatives. It aims to deliver affordable, lower-carbon energy to meet growing domestic and international demand while creating sustainable value for stakeholders. Expand Energy’s business model includes exploration and production activities supported by ancillary marketing operations and vertical integration through an assumed oilfield service business. The company manages commodity price risk through derivative instruments and maintains a strong liquidity position supported by cash on hand and credit facilities. It also pursues shareholder returns through dividends and share repurchases, balanced with debt reduction priorities.

Stellar Bancorp, Inc. operates as a bank holding company with its primary banking operations conducted through Stellar Bank. The company is regulated by federal and state banking authorities and adheres to governance standards including director independence and audit committee oversight. Stellar Bancorp has entered into a definitive merger agreement with Prosperity Bancshares, Inc., which includes the merger of Stellar Bank into Prosperity Bank. The merger agreement includes customary representations, warranties, covenants, and termination provisions. The company maintains policies to manage related person transactions and conflicts of interest. Financial disclosures include quarterly results and audit fees paid to Crowe LLP. The company is listed on the NYSE under the ticker STEL.

Amkor Technology, Inc. is the world's largest U.S.-headquartered outsourced semiconductor assembly and test service provider (OSAT) and a global leader in semiconductor packaging and test services. The company offers a comprehensive portfolio of advanced packaging, wafer-level processing, and system-in-package solutions targeting applications in smartphones, data centers, AI, automotive, and wearables. Amkor serves integrated device manufacturers, fabless semiconductor companies, OEMs, and contract foundries. Its services include wafer bump, wafer probe, wafer back-grind, package design, packaging, burn-in, system level and final test, and drop shipment. The company operates a geographically diverse manufacturing footprint with facilities in Asia, Europe, and the U.S., including a new facility under construction in Arizona and expanded capacity in Vietnam. Amkor emphasizes technology leadership through investments in heterogeneous integration, 2.5D integration, high density fan-out, silicon photonics, and power modules using advanced materials. The company focuses on profitable sales growth by expanding technology leadership, geographic footprint, and strategic partnerships with leading semiconductor companies. Its end markets include communications, computing, automotive, and consumer electronics. Amkor's business is cyclical and influenced by global economic factors and semiconductor industry cycles.

Incyte Corporation is a pharmaceutical company focused on discovering, developing, and commercializing drug products primarily in oncology and inflammation. Its lead product, JAKAFI (ruxolitinib), is approved for multiple indications and represents a substantial portion of the company's revenues. The company also markets other products such as ICLUSIG, PEMAZYRE, MONJUVI/MINJUVI, OPZELURA, ZYNYZ, and NIKTIMVO, and has licensing agreements for OLUMIANT and TABRECTA. Incyte faces competition from generic manufacturers and other pharmaceutical companies, with ongoing patent litigation to protect its product exclusivity. The company depends on third-party manufacturers for drug production and specialty pharmacies and wholesalers for distribution. Regulatory approvals, pricing and reimbursement policies, and market acceptance are critical to its commercial success. Incyte invests heavily in research and development, with inherent risks in clinical trials and regulatory processes. The company operates globally and is subject to various operational, regulatory, and market risks.

Chubb Ltd is a Swiss-incorporated holding company and the parent of the Chubb Group of Companies, a global insurance and reinsurance organization serving diverse clients worldwide. The company operates in 54 countries and territories, offering commercial and consumer property and casualty insurance, accident and health insurance, reinsurance, and life insurance. Chubb's business model emphasizes underwriting discipline, quality risk selection, and product and geographic diversification to maintain stability and profitability across market cycles. The company operates through six segments: North America Commercial P&C Insurance, North America Personal P&C Insurance, North America Agricultural Insurance, Overseas General Insurance, Global Reinsurance, and Life Insurance. Chubb's underwriting strategy focuses on disciplined pricing and risk management, supported by strong underwriting authorities and audit functions. The company distributes its products through a broad network of independent agents, brokers, digital platforms, and direct marketing channels. Chubb's strong balance sheet and capital position support its competitive advantages and growth opportunities.

Nine Energy Service, Inc. operates in the onshore oil and natural gas sector, providing completion tools and related services. The company is headquartered in Houston, Texas, and is incorporated in Delaware. It underwent a prepackaged Chapter 11 bankruptcy process beginning February 1, 2026, and emerged from bankruptcy on March 5, 2026, with a restructured capital base and board of directors. The company reported $561.9 million in revenue and a net loss of $51.3 million for the fiscal year ended December 31, 2025. Liquidity metrics as of that date include a current ratio of 1.85 and cash and equivalents of $18.4 million. The company is listed on the NYSE American exchange under the ticker symbol NINE as of March 31, 2026. The board includes members with extensive experience in energy, restructuring, and finance. The company faces risks related to compliance with NYSE listing standards, including market capitalization and share price requirements, and is pursuing a reverse stock split to address share price deficiencies.

Knowles Corporation designs and manufactures specialty electronic components including high-performance capacitors, RF filters, advanced microphones, and balanced armature speakers. The company operates globally with approximately 5,200 employees and facilities in 11 countries. It serves key markets such as medtech, defense, industrial, and electrification/energy through two segments: Precision Devices (PD) and Medtech & Specialty Audio (MSA). The PD segment focuses on custom capacitors and RF solutions for demanding applications, while the MSA segment provides hearing health and specialty audio components. Knowles sells directly to OEMs and through distributors worldwide, with major customers including WS Audiology and TTI Inc. Market trends impacting the company include increased defense spending, demographic shifts in hearing health, and trade barriers influencing domestic manufacturing. The company manages commodity price risks and emphasizes innovation and customization to maintain competitive positioning.

PDS Biotechnology Corp is a clinical-stage biotechnology company focused on developing novel immunotherapies targeting cancer. Its pipeline includes PDS01ADC, an IL-12 tumor-targeted immunocytokine undergoing Phase 2 clinical trials for metastatic castration-resistant prostate cancer and metastatic colorectal cancer. The company also develops Versamune® HPV immunotherapy candidates. PDS Biotech holds patents covering its proprietary technology and has engaged with the FDA on clinical trial endpoints. The company is headquartered in Princeton, New Jersey, and governed by a Board with extensive industry and scientific expertise. It is publicly traded on The Nasdaq Capital Market under the ticker PDSB.

Purple Innovation, Inc. is a sleep products company specializing in innovative comfort solutions based on its proprietary Hyper-Elastic Polymer gel technology. The company offers a range of premium mattresses, pillows, and related comfort products designed to provide pressure relief, temperature neutrality, and durability. Purple operates an omni-channel distribution model including direct-to-consumer e-commerce, physical showrooms, and wholesale partnerships with brick-and-mortar and online retailers. The company emphasizes vertical integration with in-house design, manufacturing, and proprietary equipment, supporting rapid innovation and scale. Purple's brand is recognized for high customer engagement and satisfaction, supported by targeted marketing and a broad product suite. The company reported Q1 2026 revenue of $95.73 million and a net loss of $30.54 million, with liquidity ratios indicating a current ratio of 1.24 and cash ratio of 0.27 as of March 31, 2026.

Pentair plc is a global provider of water treatment, fluid transfer, and related products and solutions. The company operates through multiple segments, including Flow, Water Solutions, and Pool. In 2026, Pentair reorganized its residential and irrigation flow business into the Water Solutions segment, which offers products such as water filtration systems, commercial ice machines, and water softening solutions. Pentair competes on technical expertise, product quality, service, and price against a diverse set of global and regional competitors. The company sources raw materials from multiple suppliers and manages commodity price volatility through long-term agreements. Pentair's customer base includes a concentration with its largest customer representing about 18% of net sales. The company operates globally with significant sales in the U.S., Western Europe, developing regions, and other developed markets. Pentair invests in research and development and pursues acquisitions to support growth and innovation.

BGC Group, Inc. is a publicly traded financial services company specializing in brokerage services across energy, commodities, shipping, and financial markets. The company underwent a significant corporate restructuring in mid-2023, transitioning from an Umbrella Partnership-Corporation to a Full C-Corporation, simplifying its organizational structure and consolidating its subsidiaries under BGC Group. The company provides brokerage services including carbon offset solutions and lower carbon energy transition fuels, positioning itself as a broker for the green economy. BGC Group maintains a diversified capital structure with multiple senior notes and a revolving credit facility. The board of directors includes experienced executives from affiliated firms and the financial industry. The company has been active in strategic business transactions and maintains a focus on sustainability and corporate governance.

Black Hawk Acquisition Corp is a Cayman Islands exempted special purpose acquisition company (SPAC) listed on the Nasdaq Global Market. The company’s primary business model is to identify and complete an initial business combination (DeSPAC transaction) with a target company. It has issued units, ordinary shares, and rights as part of its capital structure. The company has a convertible promissory note issued to its sponsor for working capital purposes. As of the latest quarter ended February 28, 2026, the company had limited current assets and no cash, with current liabilities significantly exceeding current assets, resulting in a low liquidity ratio. The company has received a Nasdaq notice for failing to meet minimum market value requirements but retains a compliance period to address this.

FTC Solar, Inc. is a Delaware-based company engaged in the solar energy sector, specializing in manufacturing and delivering solar tracker systems. The company operates under a Credit Agreement that imposes financial covenants and restrictions on its business activities. As of the fiscal year ended December 31, 2025, FTC Solar reported a significant net loss and liquidity ratios indicating moderate short-term financial flexibility. The company faces challenges from international trade tariffs and regulatory changes affecting the solar industry. Its governance includes a board of directors with diverse experience in renewables, finance, and operations.

Criteo S.A. operates as a global commerce intelligence platform that provides technology and insights to brands, agencies, retailers, and publishers. The company utilizes proprietary commerce data from over $1 trillion in annual transactions and applies AI innovations developed over two decades. It operates primarily through two segments: Performance Media and Retail Media. In 2025, revenue was approximately $1.945 billion, with growth driven by Retail Media. The company maintains a strong liquidity position with over $342 million in cash and equivalents as of December 31, 2025. Leadership includes CEO Michael Komasinski, who brings extensive AdTech and retail media expertise, and Chairperson Frederik van der Kooi, with deep digital advertising and corporate finance experience.

Elme Communities operates as a self-administered equity REIT with a portfolio primarily consisting of approximately 9,400 residential apartment homes and about 300,000 square feet of commercial space, mainly in the Washington, DC and Atlanta metro areas. The company focuses on ownership, development, redevelopment, and acquisition of apartment communities. It operates a single reportable segment centered on residential properties. Elme maintains REIT status by distributing a significant portion of its taxable income as dividends. The company has recently entered into a purchase agreement related to a plan of sale and liquidation of assets, reflecting a strategic shift in its business operations.

Medalist Diversified REIT, Inc. operates as a diversified real estate investment trust with a portfolio that includes commercial properties such as retail centers and automotive facilities. The company engages in strategic acquisitions, dispositions, and capital structure management to optimize its asset base and financial position. Leadership includes experienced executives and independent directors with expertise in real estate, investment banking, and technology sectors. The company maintains governance through established board committees and compliance policies. Recent transactions include the sale of significant properties and contribution of assets to a Delaware statutory trust, reflecting active portfolio management.

Lisata Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on developing novel therapies, including oncology drug candidates. The company is governed by a classified board of six directors with diverse expertise in pharmaceuticals, clinical development, finance, and legal affairs. The executive leadership team includes a President and CEO with extensive industry experience and senior officers overseeing research and development, finance, business development, and legal functions. Financial disclosures indicate the company held approximately $15.96 million in cash and equivalents as of the end of 2025, with a net loss of $16.59 million for the fiscal year. In March 2026, Lisata entered into a merger agreement with Kuva Labs Inc., which includes a cash tender offer of $5.00 per share plus contingent value rights related to regulatory milestones for its lead product candidate, certepetide. The merger agreement also provides for accelerated vesting of equity awards and customary termination fees. The company reported no related party transactions during 2025 and maintains strong liquidity ratios, reflecting a solid balance sheet position for a clinical-stage biopharmaceutical entity.

Beasley Broadcast Group, Inc. operates as a radio broadcast media company with a long-standing family control structure. The company is led by CEO Caroline Beasley and other family members in key executive roles. It is publicly traded on Nasdaq under the ticker BBGI. The company has a portfolio of radio stations and is engaged in digital revenue initiatives through investments such as Quu, Inc. The company has experienced financial challenges, including net losses and a stockholders' deficit, which have triggered Nasdaq compliance concerns. The company is actively addressing these issues through strategic financial initiatives and compliance planning.

Loma Negra Compania Industrial Argentina Sociedad Anonima is an Argentine company primarily engaged in the production and distribution of cement and related construction materials, including masonry cement, concrete, limestone, and aggregates. The company also provides logistics services through a railway concession and operates an industrial waste recycling business. It sources raw materials mainly from its own quarries and maintains a significant energy procurement strategy that includes renewable sources to comply with Argentine regulations. The company reports financials in Argentine Pesos and files annual reports with the SEC, including detailed disclosures on its accounting policies, tax obligations, and financial results.

AMERICA MOVIL SAB DE CV is a leading telecommunications provider headquartered in Mexico City, Mexico. The company offers a broad range of services including mobile telephony, fixed-line services, broadband internet, and PayTV across multiple countries in Latin America, Central America, the Caribbean, and parts of Europe. It operates a large subscriber base with millions of wireless and fixed-line customers, focusing on expanding postpaid mobile services and convergent fixed-mobile bundles to enhance customer retention and revenue growth. The company manages a complex regulatory environment and diverse economic conditions, including hyperinflationary markets such as Argentina. Financially, AMERICA MOVIL reported revenues of approximately USD 42.9 billion and net income of USD 1.36 billion for the fiscal year 2024, with liquidity ratios indicating current liabilities exceed current assets. The company maintains active shareholder distributions through dividends and share repurchases, supported by positive free cash flow generation. Recent operational highlights include strong subscriber additions and mobile service revenue growth in key markets during early 2026, alongside efforts to control costs and improve EBITDA margins [S1][S2][S3][S4][S6][N1].

EUDA Health Holdings Ltd is a foreign private issuer listed on Nasdaq, with primary operations in property management services and holistic wellness consumer products and services. The wellness segment includes bioenergy cabin therapy packages and stem cell therapy services provided through third-party treatment providers. The company has undergone strategic realignment, streamlining medical-related business units to focus on property management and wellness offerings. Management comprises experienced executives in property management and wellness sectors, supporting service delivery. EUDA has no off-balance-sheet arrangements and maintains policies for cybersecurity and insider trading compliance [S1].

LOBO TECHNOLOGIES LTD. is a high-tech company specializing in the design, manufacture, and sale of a broad range of eco-friendly electric mobility products and home-use robotic products. Its product portfolio includes e-bicycles, electric motorcycles, e-tricycles, electric off-road four-wheeled shuttles such as golf carts and elderly scooters, solar-powered vehicles, and smart products and services. The company operates four factories with over 150 employees and maintains a dealer network spanning approximately 60 countries globally. LOBO emphasizes user-centered product design, integrating customer and dealer feedback throughout the product lifecycle to deliver safe, affordable, and high-quality electric vehicles. The company pursues a dual marketing strategy combining product differentiation tailored to specific user groups and cost leadership through production and supply chain optimization. It has ISO 9001:2015 and ISO 14001:2015 certifications and is recognized as a high-tech and Eagle company by provincial authorities. The company has undergone corporate restructuring, including disposal of certain subsidiaries, to focus on its core electric vehicle business. LOBO invests significantly in research and development, particularly in intelligent urban tricycles, elderly scooters, and solar-powered e-bicycles, aiming to be a leader in green mobility solutions [S1].

Lichen International Ltd is a professional service provider operating primarily in China, focusing on financial and taxation solution services, education support services, software and maintenance services, and Pre-IPO advisory services. The company has over 20 years of experience and has been recognized as a leading management consulting service provider in China. It operates a single reportable segment and applies ASC 606 for revenue recognition, with revenues recognized either over time or at a point in time depending on the service type. The company reported a decline in total revenue from $41.48 million in 2024 to $24.52 million in 2025, with a net loss increasing to $21.96 million in 2025. Liquidity remains strong with a current ratio of 7.73 and cash equivalents of $26.91 million as of year-end 2025. Capital expenditures focus on acquisitions, software development, and office infrastructure. Recent shareholder meetings approved significant share capital increases and amendments to corporate governance documents.

Springview Holdings Ltd is a Singapore-based construction company operating through its subsidiary Springview Enterprises Pte. Ltd. The company specializes in designing and constructing residential and commercial buildings, offering services in new construction, reconstruction, additions and alterations (A&A), and other general contracting services such as renovation and design consultation. Revenue is recognized over time using the percentage of completion method based on actual contract costs relative to total estimated costs. The company relies on subcontractors and suppliers for project execution but does not have long-term contracts with them, which introduces operational risks. Springview Holdings has a history dating back to 2002 and maintains a reputation for quality work and customer relationships in the Singapore real estate market. The company faces competition from larger firms with more resources but emphasizes its market reputation and customer referrals. Financially, the company reported $6.07 million USD in revenue and a net loss of $1.83 million USD for the year ended December 31, 2025, with a strong current ratio of 3.37 indicating liquidity. The company’s customer base shows some concentration, with four customers accounting for a majority of revenue. Recent news highlights include a significant contract win and safety certification, alongside a Nasdaq compliance notification.

Zhengye Biotechnology Holding Ltd operates in the veterinary vaccine sector, producing vaccines primarily for livestock such as swine, poultry, and sheep. The company completed its initial public offering in January 2025, raising gross proceeds of $6.9 million. Its revenue for 2025 was approximately $16.6 million, reflecting a decline from previous years due to adverse market conditions in the hog industry and government macro-control policies. The company incurred a net loss of approximately $11.9 million in 2025. It has ongoing research and development activities with increased spending in 2025. Liquidity metrics as of year-end 2025 show a current ratio of 1.14 and cash ratio of 0.16. The company is actively remediating a material weakness in internal controls over financial reporting related to accounting personnel expertise. It received a Nasdaq delinquency letter for non-compliance with listing requirements in May 2025.

Ohmyhome Ltd is a publicly traded company on the Nasdaq Capital Market under the symbol OMH. The company operates primarily in the estate management sector, providing services and a technology platform for residents of private and executive condominiums in Singapore. It has a dual-class share structure with voting rights differentiated between Class A and Class B shares. The company has undertaken acquisitions to expand its service offerings, including the acquisition of Ohmyhome Property Management (S) in 2023, which added goodwill and intangible assets related to customer relationships. Ohmyhome Ltd has not declared dividends and retains earnings to fund operations and growth. The company reported significant revenue growth in 2024 but continues to operate at a net loss as of 2025. It maintains moderate liquidity with a current ratio above 1.0 and has some vendor concentration risk. Leadership changes include the appointment of Agus Prasetyo as Acting CFO in 2026, who also serves as CEO.